181 related articles for article (PubMed ID: 19816882)
1. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
[TBL] [Abstract][Full Text] [Related]
2. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM
Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
[TBL] [Abstract][Full Text] [Related]
3. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
4. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
5. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
6. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
Cowans NJ; Spencer K; Meiri H
Prenat Diagn; 2008 Feb; 28(2):121-5. PubMed ID: 18186153
[TBL] [Abstract][Full Text] [Related]
7. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction.
Al Nakib M; Desbrière R; Bonello N; Bretelle F; Boubli L; Gabert J; Levy-Mozziconacci A
Fetal Diagn Ther; 2009; 26(1):24-8. PubMed ID: 19816026
[TBL] [Abstract][Full Text] [Related]
8. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications.
D'Antonio F; Rijo C; Thilaganathan B; Akolekar R; Khalil A; Papageourgiou A; Bhide A
Prenat Diagn; 2013 Sep; 33(9):839-47. PubMed ID: 23613261
[TBL] [Abstract][Full Text] [Related]
9. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
Tao H; Wang XM; Ji XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
[TBL] [Abstract][Full Text] [Related]
10. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
Alberry MS; Maddocks DG; Hadi MA; Metawi H; Hunt LP; Abdel-Fattah SA; Avent ND; Soothill PW
Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
[TBL] [Abstract][Full Text] [Related]
11. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.
Alberry M; Maddocks D; Jones M; Abdel Hadi M; Abdel-Fattah S; Avent N; Soothill PW
Prenat Diagn; 2007 May; 27(5):415-8. PubMed ID: 17286310
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
13. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
14. Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes.
Poon LC; Musci T; Song K; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2013; 33(4):215-23. PubMed ID: 23466432
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
Vega J; Sáez G; Smith M; Agurto M; Morris NM
Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
Hogg BB; Tamura T; Johnston KE; Dubard MB; Goldenberg RL
Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
[TBL] [Abstract][Full Text] [Related]
18. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
19. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester.
Leung TY; Sahota DS; Chan LW; Law LW; Fung TY; Leung TN; Lau TK
Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
